Obliterating bronchiolitis in a patient treated with (D)-penicillamine.

Characterisation of severe obliterative bronchiolitis in rheumatoid arthritis.

[Obliterating bronchiolitis induced by D-penicillamine in the female patient with systemic scleroderma].

Bronchiolitis obliterans in a patient with localized scleroderma treated with D-penicillamine.

Bronchiolitis obliterans: high resolution CT findings and correlation with pulmonary function tests.

Beneficial effect of intravenous cyclophosphamide and oral prednisone on D-penicillamine-associated bronchiolitis obliterans.

Selected adverse reactions of D-penicillamine.

Upper and lower airway disease in penicillamine treated patients with rheumatoid arthritis.

Obliterative bronchiolitis in rheumatoid arthritis.

[The respiratory complications of D-Penicillamine therapy (author's transl)].

Bronchiolitis and bronchitis in connective tissue disease. A possible relationship to the use of penicillamine.

D-penicillamine and obliterative bronchiolitis.